Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products

This cross-sectional study evaluates the association of generic competition and changes in product coverage and cost-sharing by using Medicare data and estimated out-of-pocket costs for the oral specialty drug abiraterone.

Detalles Bibliográficos
Autores principales: Gupta, Arjun, Antonarakis, Emmanuel S., Blaes, Anne H., Booth, Christopher M., Dusetzina, Stacie B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526080/
https://www.ncbi.nlm.nih.gov/pubmed/36178694
http://dx.doi.org/10.1001/jamanetworkopen.2022.31475
Descripción
Sumario:This cross-sectional study evaluates the association of generic competition and changes in product coverage and cost-sharing by using Medicare data and estimated out-of-pocket costs for the oral specialty drug abiraterone.

Ejemplares similares